Skip to main content
Screener/Healthcare/Biotechnology

ZNTL Zentalis Pharmaceuticals, Inc.

NASDAQ
$4.27-0.73 (-14.64%)
$1.21
$6.95
$4.01
$4.83
EPS (TTM)$-1.73
P/E Ratio-2.12
Dividend Yield
Market Cap$337.4M
Volume1.33M
Prev Close$5.00
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$0-$35.4M$-0.50
Q4 '25$0-$35.2M$-0.49
Q3 '25$0-$26.7M$-0.37
Q2 '25$0-$26.9M$-0.37
Q1 '25$0-$48.3M$-0.67
Q4 '24$26.9M-$47.5M$-0.67100.0%-176.7%
Q3 '24$0-$40.2M$-0.56
Q2 '24$0-$88.3M$-1.24
Get Your Daily Market Recap